These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26635929)

  • 1. Digoxin: A systematic review in atrial fibrillation, congestive heart failure and post myocardial infarction.
    Virgadamo S; Charnigo R; Darrat Y; Morales G; Elayi CS
    World J Cardiol; 2015 Nov; 7(11):808-16. PubMed ID: 26635929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction.
    Pedersen OD; Bagger H; Køber L; Torp-Pedersen C;
    Int J Cardiol; 2005 Apr; 100(1):65-71. PubMed ID: 15820287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and non-pharmacological treatments and outcomes for new-onset atrial fibrillation in ICU patients: the CAFE scoping review and database analyses.
    Bedford J; Drikite L; Corbett M; Doidge J; Ferrando-Vivas P; Johnson A; Rajappan K; Mouncey P; Harrison D; Young D; Rowan K; Watkinson P
    Health Technol Assess; 2021 Nov; 25(71):1-174. PubMed ID: 34847987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
    Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
    J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Digitalis, a drug to be scrapped?].
    Cosmi F; Tarquini B; Mariottoni B; Cosmi D
    G Ital Cardiol (Rome); 2017 Feb; 18(2):121-128. PubMed ID: 28398365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of digoxin in atrial fibrillation: One step further in the mortality controversy from the AFFIRM study.
    Charnigo R; Khairy P; Guo J; Shohoudi A; Elayi CS
    Pacing Clin Electrophysiol; 2018 Jul; 41(7):713-719. PubMed ID: 29660142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Integrative Comparative Study Between Digoxin and Amiodarone as an Emergency Treatment for Patients With Atrial Fibrillation With Evidence of Heart Failure: A Systematic Review and Meta-Analysis.
    Zaki HA; Bashir K; Iftikhar H; Salem W; Mohamed EH; Elhag HM; Hendy M; Kassem AAO; Salem EE; Elmoheen A
    Cureus; 2022 Jul; 14(7):e26800. PubMed ID: 35971374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibitors versus digoxin for the treatment of congestive heart failure.
    Crozier I; Ikram H
    Drugs; 1992 May; 43(5):637-50. PubMed ID: 1379144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial.
    Falk RH; Knowlton AA; Bernard SA; Gotlieb NE; Battinelli NJ
    Ann Intern Med; 1987 Apr; 106(4):503-6. PubMed ID: 3548521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systolic time intervals in atrial fibrillation.
    Boudoulas H; Lewis RP; Sherman JA; Bush CA; Dalamangas G; Forester WF
    Chest; 1978 Dec; 74(6):629-34. PubMed ID: 738120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
    Fishkind D; Paris BE; Aronow WS
    J Am Geriatr Soc; 1997 Jul; 45(7):809-12. PubMed ID: 9215330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin and mortality in atrial fibrillation: a prospective cohort study.
    Hallberg P; Lindbäck J; Lindahl B; Stenestrand U; Melhus H;
    Eur J Clin Pharmacol; 2007 Oct; 63(10):959-71. PubMed ID: 17684738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should digoxin be proscribed in elderly subjects in sinus rhythm free from heart failure? A population-based study.
    Casiglia E; Tikhonoff V; Pizziol A; Onesto C; Ginocchio G; Mazza A; Pessina AC
    Jpn Heart J; 1998 Sep; 39(5):639-51. PubMed ID: 9925995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations.
    Rubin DA; Nieminski KE; Reed GE; Herman MV
    J Thorac Cardiovasc Surg; 1987 Sep; 94(3):331-5. PubMed ID: 3306163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dofetilide in patients with congestive heart failure and left ventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group.
    Møller M; Torp-Pedersen CT; Køber L
    Congest Heart Fail; 2001; 7(3):146-150. PubMed ID: 11828153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose. The SPRINT Study Group.
    Leor J; Goldbourt U; Rabinowitz B; Reicher-Reiss H; Boyko V; Kaplinsky E; Behar S
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):723-9. PubMed ID: 8573556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of digoxin in heart failure and sinus rhythm: new features of an old drug?
    van Veldhuisen DJ; de Graeff PA; Remme WJ; Lie KI
    J Am Coll Cardiol; 1996 Oct; 28(4):813-9. PubMed ID: 8837553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.